Cardiogenic Shock News and Research

RSS

Cardiogenic shock is based upon an inadequate circulation of blood due to primary failure of the ventricles of the heart to function effectively.

Impella CP pump shows survival benefit in cardiogenic shock

Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Intra-aortic balloon pump support reduces 30-day mortality in postinfarction VSR patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in cases of myocardial infarction.

8 Mar 2024

Is air pollution associated with increased incidence of myocardial infarction and cardiogenic shock?

The association between prolonged exposure to air pollution (AP) and ST-elevation myocardial infarction.

4 Mar 2024

Mayo Clinic study finds minimal impact of daylight saving time on heart health

A recent Mayo Clinic study examining the effects of daylight saving time (DST) on heart health suggests that the impact is likely minimal.

27 Feb 2024

MIT researchers develop new test for ventricular assist device suitability

Every year, around 50,000 people in the United States experience cardiogenic shock -; a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood for the body's needs.

14 Feb 2024

Heart attack breakthrough: New protocol saves 71% of patients with deadly complication

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

13 Dec 2023

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).

27 Nov 2023

In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction patients.

26 Oct 2023

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Recognizing and acting on heart attack symptoms linked to faster treatment, better outcomes

Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according to research presented at ESC Congress 2023.

22 Aug 2023

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella

A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice.

5 Jul 2023

Study reviews the diagnosis and treatment of acute myocarditis

Scientists have recently reviewed and summarized the evidence regarding diagnosing and treating acute myocarditis.

6 Apr 2023

Latest treatments for cardiac emergencies to be revealed at ESC Acute CardioVascular Care 2023

The latest evidence on the treatment of urgent heart problems will be revealed at ESC Acute CardioVascular Care 2023, a scientific congress of the European Society of Cardiology.

27 Feb 2023

Cardiac MRI of individuals with acute or post-acute COVID-19

In a recent study published in the Journal of Clinical Ultrasound, researchers in Italy reported cardiac magnetic resonance (CMR) findings in individuals with myocarditis-like syndrome during the acute phase of SARS-CoV-2 infection (AMCovS) and post-acute phase (cPACS).

3 Jan 2023

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Reduced cardiac function identified in severe COVID-19 patients in new study

In a new study, researchers assessed the cardiac function in patients experiencing severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Heavy smoking and smoke inhalation linked to poor prognosis after a heart attack

The risk of death or poor prognosis after a heart attack is more than 20-fold higher in smokers with exhaled carbon monoxide levels above 13 ppm, indicating heavy smoking and inhalation of smoke.

26 Aug 2022

International medical experts aim to use biomarker-based approaches to advance precision medicine

The diagnostics company SphingoTec GmbH (SphingoTec), announces that, during the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.

11 Aug 2022

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

New research assessed the association of smoking with COVID-19 complications.

20 Jul 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022